共 11 条
[1]
Depuydt Pieter, 2012, Ann Pharmacother, V46, pe7, DOI 10.1345/aph.1Q623
[2]
An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy
[J].
EUROPEAN JOURNAL OF CANCER,
2012, 48 (03)
:324-332
[3]
Kondo H, 2001, Nihon Kokyuki Gakkai Zasshi, V39, P215
[6]
Novartis Pharmaceuticals, 2012, AF EV PACK INS
[7]
Novartis Pharmaceuticals, 2012, ZORTR EV PACK INS
[8]
PIPERNO D, 1995, EUR RESPIR J, V8, P1018